Skip To The Main Content
Parenteral Drug Association Connecting People, Science and Regulation ®

Upcoming Events

View all
View all
View all
View all
View all
PDA ANSI

PDA and the American National Standards Institute (ANSI)

Read more
What's New
  • New online content just added to the PDA Letter! Did you miss the 2018 PDA/FDA Joint Regulatory Conference? Rebecca Stauffer, Managing Editor, PDA Letter, summarizes the presentation by Alonza Cruse, ORA, U.S. FDA, on changes to the U.S. FDA Office of Regulatory Affairs and what these changes mean for the industry
  • USP has announced a new program, Impurities for Development (IfD), to assist manufacturers in their drug development efforts.
  • Regulators from the UK and India have agreed to collaborate to tackle international medicines crime, specifically the illegal cross-border medicine trade. MHRA will send intelligence to the Directorate of Revenue Intelligence (DRI) in India, enabling the DRI to target regions suspected of sending unlicensed medicines into the UK.
Newsfeed
Buyer’s Guide
Become a Member
Lori Richter Volunteer Spotlight Volunteer of the Month is Claire Fritz Briglia
PDA Education

Advertisers

Continue the Conversation @PDA ConnectSM An Interactive Online Community!
PDA Career Center

About PDA

The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its nearly 10,000 members worldwide.

Read more

PDA Letter Free Articles